Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-04-09 Sale |
2024-04-11 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | GRAYZEL DAVID S. Director |
11,882 | $28.15 | $334,478 | 1,799,232 (Indirect) |
View |
| 2024-04-01 Sale |
2024-04-03 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
10,000 | $30 | $300,033 | 373,381 (Direct) |
View |
| 2024-04-01 Sale |
2024-04-03 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
3,325 | $31.97 | $106,317 | 26,966 (Direct) |
View |
| 2024-04-01 Sale |
2024-04-03 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Verwijs Marinus CHIEF TECHNICAL OFFICER |
5,300 | $29.19 | $154,697 | 79,400 (Direct) |
View |
| 2024-04-01 Sale |
2024-04-03 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
12,495 | $31.23 | $390,208 | 17,728 (Direct) |
View |
| 2024-03-28 Sale |
2024-04-01 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
9,000 | $29.5 | $265,500 | 92,761 (Direct) |
View |
| 2024-03-27 Sale |
2024-03-28 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
11,068 | $27.97 | $309,519 | 30,291 (Direct) |
View |
| 2024-03-25 Sale |
2024-03-27 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
3,432 | $28.01 | $96,119 | 41,359 (Direct) |
View |
| 2024-03-19 Sale |
2024-03-20 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Verwijs Marinus CHIEF TECHNICAL OFFICER |
5,300 | $26.08 | $138,243 | 84,700 (Direct) |
View |
| 2024-03-18 Sale |
2024-03-20 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
7,000 | $25.87 | $181,057 | 105,797 (Direct) |
View |
| 2024-03-18 Sale |
2024-03-20 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
35,057 | $25.9 | $908,046 | 147,580 (Direct) |
View |
| 2024-03-12 Sale |
2024-03-14 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
4,067 | $25.03 | $101,815 | 106,502 (Direct) |
View |
| 2024-03-07 Sale |
2024-03-11 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
25,933 | $25.03 | $649,205 | 203,193 (Direct) |
View |
| 2024-03-07 Sale |
2024-03-11 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
8,975 | $24.5 | $219,888 | 120,085 (Direct) |
View |
| 2024-02-23 Sale |
2024-02-27 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
511 | $19.5 | $9,965 | 6,265 (Direct) |
View |
| 2024-02-20 Sale |
2024-02-22 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
3,489 | $20.23 | $70,575 | 14,812 (Direct) |
View |
| 2024-02-05 Sale |
2024-02-07 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
4,600 | $17.45 | $80,249 | 111,539 (Direct) |
View |
| 2024-01-17 Sale |
2024-01-19 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
4,000 | $19.5 | $78,000 | 9,278 (Direct) |
View |
| 2024-01-05 Sale |
2024-01-08 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
4,600 | $19.16 | $88,116 | 116,139 (Direct) |
View |
| 2023-12-27 Sale |
2023-12-29 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
125 | $24.5 | $3,063 | 129,060 (Direct) |
View |
| 2023-12-20 Sale |
2023-12-22 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
4,000 | $19.5 | $78,000 | 22,301 (Direct) |
View |
| 2023-12-13 Sale |
2023-12-15 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
12,000 | $19.5 | $234,000 | 59,248 (Direct) |
View |
| 2023-12-05 Sale |
2023-12-07 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
4,600 | $16.3 | $74,996 | 120,739 (Direct) |
View |
| 2023-12-06 Sale |
2023-12-07 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,283 | $16.11 | $165,628 | 153,892 (Direct) |
View |
| 2023-11-27 Sale |
2023-11-29 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
12,517 | $16.24 | $203,237 | 164,175 (Direct) |
View |
| 2023-11-22 Sale |
2023-11-27 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
14,372 | $15.37 | $220,906 | 339,298 (Direct) |
View |
| 2023-11-22 Sale |
2023-11-27 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
13,800 | $15 | $207,000 | 125,339 (Direct) |
View |
| 2023-11-01 Sale |
2023-11-03 5:00 pm |
Aerovate Therapeutics Inc. | AVTE | Verwijs Marinus CHIEF TECHNOLOGY OFFICER |
970 | $10.46 | $10,149 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-04-01 Exercise |
2024-04-03 6:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
10,000 | $0 | 373,381 (Direct) |
View |
| 2024-04-01 Exercise |
2024-04-03 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
10,000 | $2.14 | 373,381 (Direct) |
View |
| 2024-04-01 Exercise |
2024-04-03 6:00 pm |
N/A 2031-12-13 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
3,325 | $0 | 26,966 (Direct) |
View |
| 2024-04-01 Exercise |
2024-04-03 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
3,325 | $10.61 | 26,966 (Direct) |
View |
| 2024-04-01 Exercise |
2024-04-03 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Verwijs Marinus CHIEF TECHNICAL OFFICER |
5,300 | $14.59 | 79,400 (Direct) |
View |
| 2024-04-01 Exercise |
2024-04-03 6:00 pm |
N/A 2032-03-20 |
Aerovate Therapeutics Inc. | AVTE | Verwijs Marinus CHIEF TECHNICAL OFFICER |
5,300 | $0 | 79,400 (Direct) |
View |
| 2024-04-01 Exercise |
2024-04-03 6:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
12,495 | $0 | 17,728 (Direct) |
View |
| 2024-04-01 Exercise |
2024-04-03 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
12,495 | $2.14 | 17,728 (Direct) |
View |
| 2024-03-28 Exercise |
2024-04-01 6:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
9,000 | $0 | 92,761 (Direct) |
View |
| 2024-03-28 Exercise |
2024-04-01 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
9,000 | $2.14 | 92,761 (Direct) |
View |
| 2024-03-27 Exercise |
2024-03-28 6:00 pm |
N/A 2031-12-13 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
11,068 | $0 | 30,291 (Direct) |
View |
| 2024-03-27 Exercise |
2024-03-28 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
11,068 | $10.61 | 30,291 (Direct) |
View |
| 2024-03-25 Exercise |
2024-03-27 6:00 pm |
N/A 2031-12-13 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
3,432 | $0 | 41,359 (Direct) |
View |
| 2024-03-25 Exercise |
2024-03-27 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
3,432 | $10.61 | 41,359 (Direct) |
View |
| 2024-03-19 Exercise |
2024-03-20 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Verwijs Marinus CHIEF TECHNICAL OFFICER |
5,300 | $14.59 | 84,700 (Direct) |
View |
| 2024-03-19 Exercise |
2024-03-20 6:00 pm |
N/A 2032-03-20 |
Aerovate Therapeutics Inc. | AVTE | Verwijs Marinus CHIEF TECHNICAL OFFICER |
5,300 | $0 | 84,700 (Direct) |
View |
| 2024-03-18 Exercise |
2024-03-20 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
7,000 | $0 | 105,797 (Direct) |
View |
| 2024-03-18 Exercise |
2024-03-20 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
4,000 | $1.74 | 105,797 (Direct) |
View |
| 2024-03-18 Exercise |
2024-03-20 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
3,000 | $2.14 | 105,797 (Direct) |
View |
| 2024-03-18 Exercise |
2024-03-20 6:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
35,057 | $0 | 147,580 (Direct) |
View |
| 2024-03-18 Exercise |
2024-03-20 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
14,500 | $10.61 | 147,580 (Direct) |
View |
| 2024-03-18 Exercise |
2024-03-20 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
20,557 | $2.14 | 147,580 (Direct) |
View |
| 2024-03-12 Exercise |
2024-03-14 6:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
4,067 | $0 | 106,502 (Direct) |
View |
| 2024-03-12 Exercise |
2024-03-14 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
4,067 | $2.14 | 106,502 (Direct) |
View |
| 2024-03-07 Exercise |
2024-03-11 6:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
25,933 | $0 | 203,193 (Direct) |
View |
| 2024-03-07 Exercise |
2024-03-11 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
25,933 | $2.14 | 203,193 (Direct) |
View |
| 2024-03-07 Exercise |
2024-03-11 6:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
8,975 | $0 | 120,085 (Direct) |
View |
| 2024-03-07 Exercise |
2024-03-11 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
8,975 | $2.14 | 120,085 (Direct) |
View |
| 2024-03-04 Option Award |
2024-03-06 6:00 pm |
N/A 2034-03-04 |
Aerovate Therapeutics Inc. | AVTE | Dable Habib J Director |
1,531 | $16.37 | 1,531 (Direct) |
View |
| 2024-02-23 Exercise |
2024-02-27 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
511 | $0 | 6,265 (Direct) |
View |
| 2024-02-23 Exercise |
2024-02-27 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
511 | $1.74 | 6,265 (Direct) |
View |
| 2024-02-20 Exercise |
2024-02-22 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
3,489 | $0 | 14,812 (Direct) |
View |
| 2024-02-20 Exercise |
2024-02-22 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
3,489 | $1.74 | 14,812 (Direct) |
View |
| 2024-02-05 Exercise |
2024-02-07 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
4,600 | $0 | 111,539 (Direct) |
View |
| 2024-02-05 Exercise |
2024-02-07 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
1,400 | $1.74 | 111,539 (Direct) |
View |
| 2024-02-05 Exercise |
2024-02-07 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
3,200 | $2.14 | 111,539 (Direct) |
View |
| 2024-01-29 Option Award |
2024-01-31 6:00 pm |
N/A 2034-01-28 |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
200,000 | $0 | 200,000 (Direct) |
View |
| 2024-01-22 Option Award |
2024-01-24 6:00 pm |
N/A 2034-01-21 |
Aerovate Therapeutics Inc. | AVTE | Pigot Timothy CHIEF COMMERCIAL OFFICER |
66,586 | $0 | 67,877 (Direct) |
View |
| 2024-01-22 Option Award |
2024-01-24 6:00 pm |
N/A 2034-01-21 |
Aerovate Therapeutics Inc. | AVTE | Verwijs Marinus CHIEF TECHNOLOGY OFFICER |
66,586 | $0 | 66,586 (Direct) |
View |
| 2024-01-22 Option Award |
2024-01-24 6:00 pm |
N/A 2034-01-21 |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
66,586 | $0 | 66,586 (Direct) |
View |
| 2024-01-22 Option Award |
2024-01-24 6:00 pm |
N/A 2034-01-21 |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
66,586 | $0 | 66,586 (Direct) |
View |
| 2024-01-22 Option Award |
2024-01-24 6:00 pm |
N/A 2034-01-21 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
66,586 | $0 | 66,586 (Direct) |
View |
| 2024-01-22 Option Award |
2024-01-24 6:00 pm |
N/A 2034-01-21 |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
66,586 | $0 | 66,586 (Direct) |
View |
| 2024-01-17 Exercise |
2024-01-19 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
4,000 | $0 | 9,278 (Direct) |
View |
| 2024-01-17 Exercise |
2024-01-19 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
4,000 | $1.74 | 9,278 (Direct) |
View |
| 2024-01-05 Exercise |
2024-01-08 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
4,600 | $0 | 116,139 (Direct) |
View |
| 2024-01-05 Exercise |
2024-01-08 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
1,400 | $1.74 | 116,139 (Direct) |
View |
| 2024-01-05 Exercise |
2024-01-08 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
3,200 | $2.14 | 116,139 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 6:00 pm |
N/A 2034-01-01 |
Aerovate Therapeutics Inc. | AVTE | Santel Donald J Director |
2,889 | $13.49 | 2,889 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 6:00 pm |
N/A 2034-01-01 |
Aerovate Therapeutics Inc. | AVTE | Dable Habib J Director |
2,964 | $13.49 | 2,964 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 6:00 pm |
N/A 2034-01-01 |
Aerovate Therapeutics Inc. | AVTE | Katabi Maha Director 10% Owner |
3,519 | $13.49 | 3,519 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 6:00 pm |
N/A 2034-01-01 |
Aerovate Therapeutics Inc. | AVTE | GRAYZEL DAVID S. Director |
3,186 | $13.49 | 3,186 (Direct) |
View |
| 2023-12-27 Exercise |
2023-12-29 6:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
125 | $0 | 129,060 (Direct) |
View |
| 2023-12-27 Exercise |
2023-12-29 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
125 | $2.14 | 129,060 (Direct) |
View |
| 2023-12-20 Exercise |
2023-12-22 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
4,000 | $0 | 22,301 (Direct) |
View |
| 2023-12-13 Exercise |
2023-12-22 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
4,000 | $1.74 | 22,301 (Direct) |
View |
| 2023-12-13 Exercise |
2023-12-15 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
12,000 | $0 | 59,248 (Direct) |
View |
| 2023-12-13 Exercise |
2023-12-15 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
12,000 | $1.74 | 59,248 (Direct) |
View |
| 2023-12-05 Exercise |
2023-12-07 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
4,600 | $0 | 120,739 (Direct) |
View |
| 2023-12-05 Exercise |
2023-12-07 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
1,400 | $1.74 | 120,739 (Direct) |
View |
| 2023-12-05 Exercise |
2023-12-07 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
3,200 | $2.14 | 120,739 (Direct) |
View |
| 2023-12-06 Exercise |
2023-12-07 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,283 | $0 | 153,892 (Direct) |
View |
| 2023-12-06 Exercise |
2023-12-07 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
2,411 | $1.74 | 153,892 (Direct) |
View |
| 2023-12-06 Exercise |
2023-12-07 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
7,872 | $2.14 | 153,892 (Direct) |
View |
| 2023-11-27 Exercise |
2023-11-29 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
12,517 | $0 | 164,175 (Direct) |
View |
| 2023-11-27 Exercise |
2023-11-29 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
2,413 | $1.74 | 164,175 (Direct) |
View |
| 2023-11-27 Exercise |
2023-11-29 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
10,104 | $2.14 | 164,175 (Direct) |
View |
| 2023-11-22 Exercise |
2023-11-27 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
14,372 | $0 | 339,298 (Direct) |
View |
| 2023-11-22 Exercise |
2023-11-27 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
2,412 | $1.74 | 339,298 (Direct) |
View |
| 2023-11-22 Exercise |
2023-11-27 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
11,960 | $2.14 | 339,298 (Direct) |
View |
| 2023-11-22 Exercise |
2023-11-27 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
13,800 | $0 | 125,339 (Direct) |
View |
| 2023-11-22 Exercise |
2023-11-27 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
4,200 | $1.74 | 125,339 (Direct) |
View |
| 2023-11-22 Exercise |
2023-11-27 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER |
9,600 | $2.14 | 125,339 (Direct) |
View |